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SUMMARY 
Background: Dietary management of phenylketonuria (PKU) requires the replacement of 
natural protein-containing foods with special low protein foods. The effect of a PKU type diet 
on factors contributing to energy balance requires investigation. 
Objective: To investigate the impact of a PKU type meal on appetite ratings, gut appetite 
hormones, thermic effect of feeding (TEF) and fat oxidation. 
Methods: Twenty-three healthy adults (mean ± SD age: 24.3 ± 5.1 years; BMI: 22.4 ± 2.5 
kg/m2) participated in a randomized, crossover design study. Each participant conducted two 
(PKU and Control) experimental trials which involved consumption of a PKU type meal and 
protein substitute drink or an isocaloric and weight matched ordinary meal and protein-
enriched milk.  Appetite, metabolic rate, fat oxidation measurements and blood collections 
were conducted for the duration of 300 minutes. On the completion of the measurements ad 
libitum buffet dinner was served.  
Results: Responses of appetite ratings, plasma concentrations of GLP-1 and PYY (P>0.05, trial 
effect, two-way ANOVA) and energy intake during ad libitum buffet dinner (P>0.05, paired t-
test) were not significantly different between the two trials. The TEF (PKU, 10.2 ±1.5%; 
Control, 13.2 ± 1.0%) and the total amount of fat oxidized (PKU, 18.90 ± 1.10 g; Control, 
22.10 ± 1.10 g) were significantly (P<0.05, paired t-tests) lower in the PKU than in the Control 
trial. The differences in TEF and fat oxidation were significant (P<0.05, paired t-tests) for the 
post-meal period. 
Conclusions: Consumption of a meal composed of special low protein foods has no detrimental 
impact on appetite and appetite hormones but produces a lower TEF and postprandial fat 
oxidation than an ordinary meal. These metabolic alterations may contribute to the increased 
prevalence of obesity reported in patients with PKU on contemporary dietary management. 
Clinical trial registration: The trial has been registered in ClinicalTrials as NCT02440932. 
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1. Introduction  
Phenylketonuria (PKU) is an autosomal recessive disorder of phenylalanine (PHE) 
metabolism resulting from the dysfunction of the enzyme phenylalanine hydroxylase and 
leading to accumulation of  PHE to neurotoxic levels [1]. PHE levels are controlled by a PKU 
diet [2, 3] which does not permit intake of natural protein foods rich in PHE, such as meat, 
cheese, poultry, eggs and milk, and restricts plant or vegetable proteins such as potatoes and 
cereals to small amounts depending on disease severity and patient’s compliance to the dietary 
treatment [4]. Thus, the diet of patients with PKU comprises predominantly of foods low in 
natural protein and prescribed special low protein foods, which are high in carbohydrate (CHO) 
and fat [5], and  PHE-free protein substitutes [6-8]. 
Despite the very restrictive nature of the PKU diet, prevalence of overweight and obesity 
in patients with PKU is similar to general population with more female PKU patients 
developing obesity than males [9-11]. From an energy balance point of view, increased body 
fatness in patients with PKU should mainly relate either to enhanced energy intake (EI) and/or 
reduced energy expenditure (EE). With respect to EI, it has been reported that PKU special low 
protein foods, such as bread, pasta, flour and breakfast cereals, provide more energy than their 
protein-containing equivalent amount of food [8, 12]. However, the aetiology of obesity in 
individuals with PKU may be also associated with effects of the PKU dietary regimen on a 
wider range of factors contributing to energy balance regulation. 
Previous research in healthy people suggested that, in comparison to meals providing the 
recommended protein amounts, high protein meals enhance satiety and postprandial responses 
of anorexigenic hormones such as PYY, GLP-1 and CCK [13-15]. It is also known that protein 
has the highest and most prolonged thermic effect of all macronutrients, followed respectively 
by carbohydrate and fat [16, 17]. In addition, enhanced protein content of the meal was reported 
to upregulate fat oxidation [15, 17, 18]. Thus, meals based on PKU special low protein foods 
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can be expected to have a detrimental impact on appetite and satiety, leading to an enhanced 
EI, and simultaneously attenuate TEF and fat oxidation, factors known to contribute 
independently to increased obesity risk [19].  
This is a mechanistic study aimed at investigation of the impact of meal based on PKU 
special low protein foods on subjective appetite scores, gut appetite hormones, thermic effect 
of feeding and postprandial fat oxidation in healthy individuals. 
 
2. Materials and methods 
 Participants 
      Participants of this study were essentially healthy women and men with body mass index 
(BMI) < 27 kg/m2, recruited by advertisements and word of mouth. Study participants were 
required to be non-smokers, to have stable body weight for one month prior to study enrolment, 
and were not taking any medication, nutritional supplement or being on a special diet. Female 
participants were not pregnant and had no disturbances in menstrual cycle. Exclusion criteria 
included chronic illness, eating disorders and history of gastrointestinal operations which could 
interfere with the results of the study. Written informed consent were obtained prior 
commencing the study. The Ethics Committee of the College of Medical, Veterinary and Life 
Sciences, Glasgow University approved the study. 
 
 Study design 
The study applied a randomized, crossover design with two sequenced experimental trials, 
separated by one week. A randomization scheme was generated using the website 
(randomization.com) to allocate participants to the experimental trials. Trials were marked as 
Control and PKU by the researcher. Each participant started first trial according to allocated 
trial randomization. On the morning of each experiment trial, participants reported to the 
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metabolic research unit between 8:00 and 9:00 after an overnight fast. Height, body mass, body 
fat, and resting metabolic rate (RMR) were measured. A cannula was introduced into an 
antecubital vein and after an interval of 10 min, a baseline blood sample was obtained. 
Subsequently, an appetite questionnaire was completed. Within 5 min, participants were then 
asked to consume 174 ml of either a PKU protein substitute drink (PKU Cooler20, white, 
Vitaflo® UK) (PKU trial) or skimmed milk drink enriched with a mixture of protein powder 
(Spectrum 12, 10 g and Iso 97 whey, 6 g) (Control trial). The drinks were isocaloric, weight 
matched and had a similar macronutrient composition (Table 1). PKU protein substitute 
provided 7.8 gm of sugar and 1.6 g of complex of CHO, while in Control drink all 8.4 g of 
CHO were sugars. Ninety minutes after drink consumption, the meal was served. The PKU 
meal comprised of protein free cheese sandwich (2 slices of bread Juvela®, 60 g; and 2.5 cheese 
slices Violife®, 50 g); mini crackers Vitaflo®, 20 g; chocolate cookies Juvela®, 10 g; and a glass 
of tap water. The Control meal comprised of a cheese sandwich of (2 slices of white bread 
Warburtons, 57 g; and 2 Lighter Mature cheese slices Tesco, 50 g); crackers Ritz®, 20 g; 
Everyday Value chocolate chip cookies Tesco, 10 g; and a glass of tap water. The meals were 
isocaloric and weight matched, but differed in macronutrient composition (Table 1). In Control 
trial lunch meal provided 22.6 grams of protein (18% of energy intake), which is close to 
average protein content of a typical lunch [20], while the meal based on PKU special low 
protein foods, protein content was negligible and consisted only of 0.31 grams (0.2% of energy 
intake). Participants were asked to consume the entire meal within 20 min. Appetite 
questionnaires were obtained and blood samples were collected at 30, 60 and 90 min post-
drink, and at 120, 150, 180, 210, 240 and 300 min post meal, whilst metabolic rate was 
measured every 30 seconds for the duration of 20 min after each blood sample. After the 
completion of the last measurement, the participants were presented with an ad libitum buffet 
test meal, which is an established and reproducible method to assess under laboratory 
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conditions the spontaneous EI and macronutrient preferences [21]. Water was available 
throughout the trial, but intake was replicated in the second trial and consumption time was 
matched. During the two days before the first trial, participants weighed and recorded all foods 
and drinks consumed and were asked to replicate this intake during the two days preceding the 
second trial. In addition, for two days prior the experimental trials participants refrained from 
exercise and alcohol intake. 
 
 Appetite ratings 
The validated Visual Analogue Scale (VAS) which consists of 100 mm lines was used to 
measure feelings of hunger, satiety, fullness, prospective food consumption and desire to eat.  
Participants were asked to place a vertical mark on the horizontal line at a point corresponding 
to their feelings at that time. The lines were anchored by most-positive (e.g. I am not hungry) 
and most-negative (e.g. never been hungrier) feeling words from the right to the left 
respectively. 
 
 Metabolic rate  
Measurements of the rate of oxygen consumption (V̇O2) and rate of carbon dioxide production 
(V̇CO2), and rate of energy expenditure (EE) were conducted by means of computerised open-
circuit ventilated-hood system (Oxycon Pro, Care Fusion, Germany).  Each measurement was 
carried out for 20-25 minutes while participants were laying comfortably in the supine position. 
The data collected during first 5 minutes were discarded.  
TEF was calculated as percentage increase in EE above RMR, and as increase in EE as 
percentage of energy intake. The cumulative TEF was calculated by multiplying the duration 
of the experimental trial (300 min) by the difference between the mean value of the postprandial 
metabolic rate and the metabolic rate measured at rest.  An alcohol-burning validation test was 
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conducted every week and revealed averaged coefficient variation of 1.7. Volume and gas 
calibrations were performed prior to each measurement and were accepted if differences were 
≤ ±1%. 
 
 Anthropometric and body composition measurements 
Measurements were taken upon arrival in the fasted state while the participants wearing 
light cloths and without shoes at the metabolic research unit. All participants were measured in 
privacy. Height was measured to the nearest 0.5 cm using a stadiometer (Seca, Leicester, UK). 
Body mass was measured by a Tanita foot to foot scale (TANITA-TBF-310, Cranela, UK). 
The same scale was utilized to measure body composition by bioelectrical impedance analysis. 
The body mass index (BMI) was derived as weight (kg) divided by height (m) squared (kg/m2). 
 
 Blood analysis 
Venous blood samples were collected into EDTA vacuette tubes (Greiner Bio-One, 
Kremsmünster, Austria). After centrifugation (4°C, 3,000 rpm for 15 min) the plasma was 
collected and frozen at -80°C until further analysis. The blood samples used for the 
determination of GLP-1 and PYY were pipetted into eppendorf tubes containing Aprotinin 
(400 kIU activity per ml, SigmaeAldrich, UK) and centrifuged at 14,000 rpm for 4 min. 
Subsequently 300 μL of plasma was aliquoted into eppendorf tubes for the storage at -80°C. 
Hexokinase method (Randox Laboratories Ltd., Crumlin, UK) was used to measure glucose 
concentrations. ELISA kits were used to measure concentrations of plasma insulin (Mercodia 
AB, Uppsala, Sweden), active GLP-1 (Merck EMD Millipore, Millipore, Billerica, MO, USA) 
and total PYY (Merck EMD Millipore, Millipore, Billerica, MO, USA). CVs were <3% for the 
glucose, <4% for the insulin and, <8% for the GLP-1 and PYY assays. 
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 Ad libitum buffet meals 
Ad libitum buffet meals were composed of a variety of commonly used foods and included 
a starter, main dish, two side dishes and a sweet, providing energy of approximately three times 
what participants would normally consume (~5 MJ). The participants were advised to consume 
the meal until they reach comfortable fullness. The food was cut into smaller pieces to eliminate 
portion related cues. The offered and leftover foods were weighed by using an electronic 
kitchen scale (Salter Housewares Ltd., Tonbridge, U.K.). The participants were blinded to the 
actual purpose of the buffet meals and thus did not know that the intake of energy and 
macronutrients was measured. 
 
 Macronutrient and energy intake 
The macronutrient and energy provided by drinks and meals, and EI during at ad libitum 
buffet was calculated using the dietary software Windiets 2010 (The Robert Gordon University, 
Aberdeen, Scotland, UK).  
 
 Statistical analyses 
Data were assessed for normality of distribution using Anderson-Darling test. Data for the 
responses during the experimental trials were analysed using two-way repeated measures 
ANOVA, followed by post hoc Tukey test. Time averaged values for the post-drink (0-90 min), 
post-meal (90-300 min) and the entire period of the experiment trial (0-300 min), calculated as 
the time averaged areas under the variable versus time curve (AUC), and the EI of the buffet 
meal were compared by paired t-test.  Statistical analyses were performed using Statistica 
(version 10.0; StatSoft, Inc., Tulsa, OK) and Minitab (version 17.3.1; Minitab, Inc., State 
College, PA). 
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3. Results 
3.1. Participants  
      Of 30 eligible participants, 4 individuals declined to take part in the study because of time 
commitments, and thus 26 participants underwent randomization. Two participants were 
excluded, as prior to the second experimental trial they did not replicate their food intake while 
one participant dropped out due to having difficulty to ingest the PKU protein substitute drink.  
Thus, the study was completed by 23 participants, of which 11 were women with a mean (±SD) 
age of 22.9 ± 1.0 years, BMI of 21.3 ± 1.8 kg/m2 and body fat mass of 13.0 ± 5.4 kg, and 12 
men with age of 25.7 ± 6.7 years, BMI of 23.3 ± 2.7 kg/m2 and body fat mass of 11.9 ± 5.5 kg. 
 
3.2. Appetite ratings 
      Responses of appetite scores during the PKU and the Control trial are presented in Fig. 1. 
Responses of all appetite measures were not significantly different between the PKU and the 
Control trials (P>0.05, trial effects, two-way ANOVA).  Time averaged appetite scores were 
also not significantly (P>0.05, paired t-tests) different between the PKU and the Control trials 
during both post-drink and post-meal periods (Table 2). 
 
3.3. Appetite hormones, glucose, and insulin   
Responses of plasma concentrations of GLP-1 and PYY were not significantly (P>0.05, 
trial effects, two-way ANOVA) different between the two trials (Fig. 2). Time averaged plasma 
concentrations of GLP-1 and PYY were also not significantly (P>0.05, paired t-tests) different 
between two trials while time averaged concentrations of insulin and glucose were significantly 
(P<0.05, paired t-tests) higher in the PKU trial than in the Control trial (Table 3). The 
differences in time averaged plasma concentrations of insulin and glucose were significant (P< 
0.05, paired t-tests) for both post-drink and post-meal periods. 
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3.4. Metabolic rate and thermic effect of feeding 
      Resting metabolic rate (RMR) did not differ between trials (PKU, 4.14 ± 0.12 kJ; Control, 
4.10 ± 0.13 kJ, P=0.4, paired t-test). Metabolic rate measured before and after drink and meal 
intake is illustrated in Fig. 3.  Analysis of two-way repeated measures ANOVA showed that 
the postprandial responses of metabolic rate were significantly different between the two trials 
(P<0.05, trial effect), with the value at 90 minutes post-drink intake being significantly 
(P<0.05) higher and nearly all values of the post-meal period significantly (P<0.05) lower in 
the PKU trial than in the Control trial. Differences between the PKU and the Control trials for 
TEF, calculated as percentage increase in EE above RMR and the relative increase in EE 
(expressed as percentage of energy provided by the drink), were significant (P< 0.05, paired t-
tests) only for the post-meal period (Table 4).  The cumulative difference in energy expended 
above the RMR during the entire period of the experimental trials was 40.9 ± 15.8 kJ. 
  
3.5. Fat and CHO oxidation  
Data on the time average rates of fat and CHO oxidation and the time averaged respiratory 
exchange ratios (RER) are presented in Table 5 and the total amount of fat and CHO oxidized 
in Fig. 4. Following drink intake differences in the rate and the total amount of fat and CHO 
oxidized and the RER were not significantly (P>0.05, paired t-tests) different between the PKU 
and the Control trial. During the post-meal period and the entire period of the experimental 
trial, the rate and amount of fat oxidized was significantly (P<0.05, paired t-tests) lower and 
the amount of CHO oxidized significantly (P<0.05, paired t-tests) higher in the PKU than in 
the Control trial. Time averaged values of RER during the post-meal period and the entire 
period of the experimental trial were significantly lower (P<0.05, paired t-tests) in the Control 
than in the PKU trial.  
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3.6. Energy and macronutrient intake during ad libitum buffet dinner 
During the ad libitum buffet dinner energy (PKU, 5.0 ± 0.3 MJ; Control, 5.3 ± 0.3 MJ), fat 
(PKU, 58 ± 4 g; Control, 62 ± 4 g), carbohydrate (PKU, 124 ± 9g; Control, 130. ± 9 g), and 
protein (PKU, 37 ± 5 g; Control, 38 ± 4 g,) intake were not significantly (P>0.05, paired t-
tests) different between the PKU and the Control trials. 
 
4. Discussion 
This study reports for the first time that the consumption of a meal based on PKU special 
low protein foods, lacking in protein and composed of CHO and fat, has no detrimental impact 
on subjective appetite measures, appetite regulating gut hormones and subsequent EI during 
ad libitum buffet dinner, however it does diminish the TEF and reduces postprandial fat 
oxidation. Collectively, these data suggest that long-term adherence to a PKU dietary regimen 
may potentially contribute to the development of overweight and obesity. Although the trend 
of obesity and overweight in PKU is similar to that in general population [9-11], our data 
suggests that development of obesity in PKU patients may be related to wider spectrum of risk 
factors. 
One of the study aims was to investigate whether meal based on PKU special low 
protein foods has a detrimental impact on appetite scores and plasma concentrations of PYY 
and GLP-1. Thus, study participants were investigated in a counter-balanced manner after the 
consumption of 2.0 MJ containing Control meal (18% of energy from protein, and 36 % and 
47 % of energy from CHO and fat, respectively) and after an isocaloric PKU type meal lacking 
protein (54 % and 46 % energy from CHO and fat, respectively). Regardless of the differences 
in the macronutrient composition of the two meals, subjective appetite and satiety scores and 
plasma concentrations of PYY and GLP-1 during the post-meal period were not significantly 
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different between the PKU and the Control trials. In addition, EI during the subsequent ad 
libitum buffet style meal consisted of approximately 5 MJ and was also not significantly 
different between the two trials. Thus, the hypothesis that whole protein lacking and CHO and 
fat based PKU type meals detrimentally affect appetite and satiety regulation cannot be 
supported by our findings. This, when combined with other evidence [13-15], suggests that 
changes in satiety and appetite regulating hormones might be expected when the protein 
content of a meal becomes higher rather than lower in comparison to the protein intake 
provided by the habitual diet. Regardless of PKU meal based on special low protein foods 
having no impact on appetite hormones, the concentrations of GLP-1 after ingestion of PKU 
protein substitute drink tended to be higher than after milk based drink. This most likely 
coincided with greater increase in plasma concentrations of amino acids, which have been 
reported to be related to appetite hormones and satiety responses [22]. 
As expected, due to higher CHO content of the PKU lunch, plasma glucose and insulin 
glucose responses during post lunch period were significantly higher in the PKU than the 
Control trial. Plasma glucose and insulin glucose responses after drink intake were also 
significantly higher in the PKU than in the Control trial. This difference was found regardless 
the glycemic index of the PKU protein substitute drink being as low as 19% (value provided 
on request from the manufacturer). Therefore, significantly higher glucose and insulin 
concentrations in the PKU trial can be explained by protein substitute drink being composed 
of free amino acids and Control drink providing whole protein. It is known that ingestion of 
free amino acids in comparison to ingestion of equivalent amount of whole protein induces 
higher insulin [23] and glucose [24] responses. Thus, finding of enhanced postprandial 
responses of insulin and glucose found after both consumption of PKU protein substitute drink 
and lunch implies that long term PKU type dietary regimen may lead to the development of 
insulin resistance. 
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This is the first study investigating how a PKU type meal modifies TEF, a metabolic 
factor known to contribute to the regulation of energy balance and thus development of 
overweight and obesity [19]. In accordance with findings that TEF of separate nutrients is 
highest for protein [15-17], we found that during post-meal and the entire period of the 
experimental trial TEF was significantly lower in the PKU than in the Control trial, and that 
the cumulative difference in energy expended above RMR between trials lasting for 5 hours 
consisted of approximately 41 kJ. While this is a small difference and TEF varies within the 
range of 5–15% of total daily EE, long-term consumption of meals based on PKU medical 
foods can result in diminished daily EE and induce body weight gain of approximately 1 kg in 
a period of a single year [25]. Thus, unfavourable attenuation of TEF induced by PKU type 
dietary regimen may be among the physiological mechanisms explaining the risk of obesity in 
patients with PKU [9-11]. 
Previous evidence suggests that reduced fat oxidation promotes a positive fat balance 
and is one of the multifactorial origins of obesity [19]. Thus, we investigated how a PKU 
protein substitute and meal impact postprandial fat oxidation. We found that during the post-
meal and the entire period of the experimental trial the amount of fat oxidized was significantly 
lower and the RER significantly higher in the PKU than in the Control trial. Diminished fat 
oxidation found in the PKU trial can be explained by the enhanced CHO content [15, 18] and 
therefore higher insulin response, and possibly lack of protein [18] in the PKU meal. Thus, 
regardless of the leading mechanism involved in reduced fat oxidation following the PKU 
meal, the obtained data suggest that the increased overweight and obesity reported in patients 
with PKU [9-11] may, at least in part, be related to the detrimental impact of PKU type foods 
on fat oxidation. Thus, future studies should investigate whether fat oxidation of the PKU 
population differs from that of matched controls and if so, how this affects energy balance and 
obesity in this group of patients. 
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Since the required amount of amino acids in a PKU type diet is obtained from 
consuming PKU protein substitutes [6, 7], the design of the experimental trial aimed to mimic 
a realistic scenario encountered in the daily life of patients with PKU and thus also involved 
consumption of the typical PKU protein substitute. The PKU protein substitute drink consisted 
of L-amino acids (free from PHE) while the Control drink was whole protein-enriched milk. 
The drinks were energy and volume matched and consumed 90 minutes prior to the intake of 
the corresponding meal. We found that appetite scores and plasma GLP-1 and PYY responses, 
as well as rate of fat oxidation and RER measured for 90 minutes after the PKU protein 
substitute drink, were not significantly different from the responses found after the intake of 
the Control drink. The TEF during the post-drink period was also not different between the 
PKU and the Control trials. However, at 90 minutes after drink intake, metabolic rate was 
significantly higher in the PKU than the Control trial.  This enhancement in the metabolic rate 
was counterbalanced quickly after the consumption of the PKU type meal. Thus, when 
combined, findings of the post-drink and post-meal periods, imply that the PKU type dietary 
regimen may have adverse effect on energy balance due to the consumption of special low 
protein foods rather than the intake of the PKU protein substitute drink.  
This study is not without limitations. Study participants were healthy men and women. 
We appreciate that the responses found in healthy individuals may not be applicable to patients 
with PKU. Therefore, future studies should investigate how measures considered in this study 
are impacted by meal based on special low protein foods consumed by patients with PKU. The 
relevance of the attenuated TEF and reduced postprandial fat oxidation for the enhanced 
prevalence of obesity reported in the PKU population [9-11] should be confirmed by future 
studies comparing how these factors are influenced by long-term adherence to meals based on 
PKU special low protein foods and how they differ between patients with PKU and healthy 
matched controls. It can be argued that the 90 minute interval used between drink and meal 
15 
 
intake is another limitation of this study as in clinical practice of PKU management dietitians 
advise protein substitute intake in very close proximity to the meal [26]. On the other hand, it 
has been reported that a reasonable proportion of patients with PKU fail to consume prescribed 
protein substitutes [5, 27, 28]. Future studies should investigate combined effect of both PKU 
protein substitute and meals based on special low protein foods on research outcomes of this 
study. The responses of gut hormones were measured in a subset of the volunteers since 
research previously conducted by us [29] and others [15, 18] has shown that using this number 
allowed identification of meaningful and statistically significant differences in plasma 
concentrations of PYY and GLP-1. 
In conclusion, the findings of this study suggest that consumption of a meal composed 
of PKU special low protein foods has no detrimental impact on subjective appetite ratings and 
appetite hormones, yet produces a lower TEF and postprandial fat oxidation than an ordinary 
meal. These metabolic alterations may be amongst the factors which contribute to the origins 
of obesity in people with PKU on contemporary dietary management. 
 
Acknowledgments 
We gratefully acknowledge Vitaflo® UK for providing free PKU protein substitute drink and 
mini crackers for the study. We thank the volunteers who participated in the study. 
 
Statement of authorship 
DM, KG, HA, BC designed the study; HA, AMN, ME recruited participants, conducted 
experimental trials; HA, AMN performed plasma analyses, conducted statistical analyses; HA, 
DM drafted the original manuscript; KG, AMN, BC, ME contributed to the drafting of the 
manuscript and its revisions.   
 
16 
 
Conflict of interest statement 
No authors have conflicts of interest to declare. 
 
Funding sources 
This study was conducted as a part of the PhD of Hani Alfheeaid, funded by Government of 
Saudi Arabia, Saudi Embassy in London, UK.
17 
 
Fig. 1. Mean ± SEM responses of hunger, satiety, fullness, desire to eat and prospective food 
consumption (PFC) scores in the PKU and the Control trials (n = 23). Analysis by two-way 
repeated measures ANOVA showed that for all appetite measures differences were not 
significantly different between two trials (P<0.05, trial effects). Statistical analyses based on 
time-averaged scores are given in Table 2. 
 
Fig. 2. Mean ± SEM responses of plasma concentrations of glucagon-like peptide-1 (GLP-1), 
peptide YY (PYY) in the PKU and the Control trials (n = 12). Analysis by two-way repeated 
measures ANOVA showed that differences for both hormones were not significantly different 
between two trials (P>0.05, trial effects). Statistical analyses based on time-averaged 
concentrations are given in Table 3. 
 
Fig. 3. Mean ± SEM responses of metabolic rate in the PKU and the Control trials (n = 23). 
Analysis by two-way repeated measures ANOVA showed that metabolic rate was significantly 
lower in the PKU than in the Control trial (P<0.05, trial effect); * P < 0.05, ** P < 0.03, *** P 
< 0.02, **** P < 0.001 (Tukey t-test). Statistical analyses for TEF calculate as % increase in 
EE above RMR and as increase in EE as % of EI in are given in Table 4. 
 
Fig. 4. Mean ± SEM amount of fat and CHO oxidized during the post-drink (0-90 min) and 
post-meal (90-300 min) and the entire period (0-300 min) in the PKU and the Control trials (n 
= 23). * P < 0.005; ** P < 0.001 (paired t-test). Statistical analyses based on time-averaged 
rate of fat and CHO oxidation and time averaged value of respiratory exchange ratio are given 
in Table 5. 
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Table 1 
Energy, fat, carbohydrate and protein provided by drinks and meals in the 
Control and the PKU trials. 
 Drink Meal 
 Control PKU Control PKU 
Energy (MJ) 0.51 0.52 2.0 2.0 
Fat (g) 0.7 0.9 25.7 24.4 
CHO (g) 9.4 9.2 44.5 63.7 
Protein (g) 20 20 22.6 0.31 
Energy from fat (%) 5.0 6.7 46.8 46.4 
Energy from CHO (%) 30.3 29.4 35.8 53.8 
Energy from protein (%) 64.5 63.8 18.0 0.2 
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Table 2 
Time-averaged subjective appetite scores (mm) during post-
drink (0-90 min), post-meal (90-300 min) and the entire period 
(0-300 min) in the Control and the PKU trial. 
 Control PKU P value 
Post-drink    
Hunger 58.6 ± 3.6 51.8 ± 3.5 0.12 
Satiety 25.7 ± 2.5 31.7 ± 2.7 0.11 
Fullness 23.2 ± 2.7 29.01 ± 3 0.17 
Desire to eat 64.4 ± 3.4 63.2 ± 3.2 0.65 
PFC 26.8 ± 2.7 28.4 ± 2.7 0.77 
Post-meal    
Hunger 53.2 ± 3.5 53.9 ± 3.6 0.84 
Satiety 49.8 ± 3.7 52.4 ± 3.4 0.43 
Fullness 48.6 ± 3.5 51.4 ± 3.5 0.38 
Desire to eat 58.8 ± 3.2 55.9 ± 3.2 0.43 
PFC 48.9 ± 3.5 50.8 ± 3.5 0.26 
Over 300 min    
Hunger 48.7 ± 2.9 48 ± 3.0 0.82 
Satiety 40.1 ± 2.8 43 ± 2.4 0.27 
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Fullness 38.7 ± 2.8 41.7 ± 2.7 0.27 
Desire to eat 53.8 ± 2.7 51.8 ± 2.6 0.46 
PFC 39.8 ± 2.7 41.2 ± 2.7 0.36 
All values are means ± SEM, n = 23 
PFC, prospective food consumption 
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Table 3 
Time-averaged concentrations of GLP-1, PYY, glucose and insulin for post-
drink (0-90 min), post-meal (90-300 min) and the entire period (0-300min) 
in the Control and the PKU trials. 
 Control PKU P value 
GLP-1 (pmol/L)a    
Post-drink 4.12 ± 0.44 4.34 ± 0.46 0.09 
            Post-meal 5.03 ± 0.74 4.77 ± 0.52 0.64 
Over 300 min 4.76 ± 0.65 4.64 ± 0.50 0.96 
PYY (pg/mL)    
Post-drink 91.50 ± 17.4 93.00 ± 15.8 0.70 
            Post-meal 144.60 ± 16.8 133.3 ± 15.6 0.15 
            Over 300 min 128.7 ± 16.8 121.2 ± 15.4 0.22 
Insulin (mU/L)    
            Post-drink 12.70 ± 1.4 15.30 ± 2.18 0.04 
            Post-meal 18.60 ± 2.31 26.34 ± 3.41 0.01 
           Over 300 min 16.83 ± 2.01 23.03 ± 2.92 0.01 
Glucose (mmol/L)    
           Post-drink 4.22 ± 0.15 4.40 ± 0.12 0.02 
           Post-meal 4.77 ± 0.14 5.08 ± 0.22 0.02 
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           Over 300 min 4.61 ± 0.14 4.88 ± 0.18 0.01 
All values are means ± SEM, n = 12 
a Statistical analysis conducted on log transformed values 
GLP-1, glucagon-like peptide-1; PYY, peptide YY 
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Table 4 
Thermic effect of feeding calculated as percentage (%) increase in EE 
above RMR and as increase in EE as percentage (%) of EI in the 
Control and the PKU trials. 
 Control PKU P value 
Increase above RMR (%) 
Post-drink 8.6 ± 1.1 10.1 ± 1.2 0.301 
Post-meal  15.6 ± 1.2 10.3 ± 1.4 0.004 
Over 300 min 13.2 ± 1.0 10.2 ± 1.5 0.056 
Increase as % of EI 
Post-drink 6.1 ± 0.7 7.0 ± 0.7 0.35 
Post-meal  6.6 ± 0.5 4.3 ± 0.5 0.001 
Over 300 min 6.4 ± 0.4 4.8 ± 0.5 0.023 
All values are means ± SEM, n = 23 
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Table 5 
Time-averaged values of the rate of fat and carbohydrate oxidation, and respiratory 
exchange ratio (RER) during post-drink (0-90 min), post-meal (90-300 min), and 
the entire period (0-300 min) in the Control and the PKU trials. 
 Control PKU P value 
 Fat oxidation (g/min)    
Post-drink 0.08 ± 0.00 0.08 ± 0.00 0.186 
Post-meal 0.08 ± 0.00 0.07 ± 0.00 <0.001 
Over 300 min 0.08 ± 0.00 0.07 ± 0.00 0.002 
CHO oxidation (g/min)    
Post-drink 0.08 ± 0.00 0.10 ± 0.01 0.155 
Post-meal 0.11 ± 0.00 0.13 ± 0.00 0.006 
Over 300 min 0.10 ± 0.00 0.12 ± 0.00 0.013 
RER    
Post-drink 0.79 ± 0.007 0.81 ± 0.010 0.072 
Post-meal 0.81 ± 0.005 0.83 ± 0.008 0.002 
Over 300 min 0.80 ± 0.005 0.82 ± 0.007 0.003 
All values are means ± SEM, n = 23 
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